Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study

被引：0
|
作者：
Ghusn, Wissam [1 ]
Fansa, Sima [1 ]
Anazco, Diego [1 ]
Tama, Elif [2 ]
Nicolalde, Bryan [1 ]
Gala, Khushboo [1 ]
Cifuentes, Lizeth [1 ]
De La Rosa, Alan [1 ]
Sacoto, Daniel [1 ]
Campos, Alejandro [1 ]
Feris, Fauzi [1 ]
Acosta, Andres [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Jacksonville, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1485
引用
收藏
页码：S1127 / S1128
页数：2
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15
  • [32] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [33] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [34] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [35] The clinical and patient reported outcomes (PROs) profile of patients with non-alcoholic fatty liver disease (NAFLD) from real-world practices varies across the world
    Younossi, Zobair
    Yilmaz, Yusuf
    Yu, Ming-Lung
    El Kassas, Mohammed
    Castellanos-Fernandez, Marlen
    Wong, Vincent Wai-Sun
    Isakov, Vasily
    Duseja, Ajay Kumar
    Mendez-Sanchez, Nahum
    Papatheodoridis, George
    Chan, Wah-Kheong
    George, Jacob
    Fan, Jian-Gao
    Bugianesi, Elisabetta
    Eguchi, Yuichiro
    Younes, Ziad H.
    Romero Gomez, Manuel
    Roberts, Stuart
    Gordon, Stuart C.
    Hamid, Saeed
    Ahmed, Aijaz
    Ong, Janus
    Alqahtani, Saleh
    Lam, Brian
    Ziayee, Mariam
    Younossi, Issah
    Nader, Fatema
    Racilla, Andrei
    Stepanova, Maria
    JOURNAL OF HEPATOLOGY, 2020, 73 : S111 - S111
  • [36] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [37] Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
    Goyal, Omesh
    Nohria, Sahil
    Goyal, Prerna
    Kaur, Jaskirat
    Sharma, Sarit
    Sood, Ajit
    Chhina, Rajoo Singh
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [38] Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
    Omesh Goyal
    Sahil Nohria
    Prerna Goyal
    Jaskirat Kaur
    Sarit Sharma
    Ajit Sood
    Rajoo Singh Chhina
    Scientific Reports, 10
  • [39] EFFECTS OF METABOLIC PHARMACOTHERAPY IN REAL WORLD PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Eghbali, Shabnam
    Newberry, Carolyn
    Yeung, Michele
    Sharaiha, Reem
    Kumar, Sonal
    HEPATOLOGY, 2022, 76 : S847 - S847
  • [40] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
12345